CD 24, CD24 molecule, CD24A, FLJ22950, FLJ43543, MGC75043
CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers.
Lyophilized from 0.22 µm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Sequenz:
SETTTGTSSNSSQSTSNSGLAPNPTNATTKAAG
Target-Kategorie:
CD24-VLP
Application Verdünnung:
Lyophilized from 0.22 µm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Anwendungsbeschreibung:
Cross-Reactivity: Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage,it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA,5% HSA,10% FBS or 5% Trehalose),and aliquot the reconstituted protein solution to minimize free-thaw cycles., ResearchArea: Biosimilar Drug Targets, Bio-Markers & CD Antigens
Immobilized Human CD24 VLP at 0.5 µg/mL (100 µL/Well) on the plate. Dose response curve for Anti-CD24 Antibody, hFc Tag with the EC<,sub>,50<,/sub>, of 16.4ng/mL determined by ELISA.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
